Correlation Between Blueprint Medicines and Cytokinetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Cytokinetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Cytokinetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Cytokinetics, you can compare the effects of market volatilities on Blueprint Medicines and Cytokinetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Cytokinetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Cytokinetics.

Diversification Opportunities for Blueprint Medicines and Cytokinetics

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Blueprint and Cytokinetics is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Cytokinetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytokinetics and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Cytokinetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytokinetics has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Cytokinetics go up and down completely randomly.

Pair Corralation between Blueprint Medicines and Cytokinetics

If you would invest  5,200  in Cytokinetics on September 10, 2025 and sell it today you would earn a total of  1,367  from holding Cytokinetics or generate 26.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy1.59%
ValuesDaily Returns

Blueprint Medicines Corp  vs.  Cytokinetics

 Performance 
       Timeline  
Blueprint Medicines Corp 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Blueprint Medicines Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Blueprint Medicines is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Cytokinetics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cytokinetics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Cytokinetics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Blueprint Medicines and Cytokinetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Blueprint Medicines and Cytokinetics

The main advantage of trading using opposite Blueprint Medicines and Cytokinetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Cytokinetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will offset losses from the drop in Cytokinetics' long position.
The idea behind Blueprint Medicines Corp and Cytokinetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Correlations
Find global opportunities by holding instruments from different markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.